Andrea Gillespie

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 665 citations · Full text

Medicine, Neurology, Oncology +16

NF1 plexiform neurofibroma growth rate by volumetric MRI

Eva Dombi, Jeffrey Solomon, Andrea Gillespie et al. · Neurology · 2007 · 200 citations

Medicine, Neurology, Pediatrics +17

Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci et al. · Journal of Clinical Oncology · 2006 · 145 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity

Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic et al. · Cancer Discovery · 2023 · 115 citations

Medicine, Immunology, Oncology +17

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Brigitte C. Widemann, Eva Dombi, Andrea Gillespie et al. · Neuro-Oncology · 2014 · 114 citations · Full text

Medicine, Neurology, Pharmacology +17